Vivianne Malmström Selected Research

Vivianne Malmström Research Topics

Disease

58	Rheumatoid Arthritis 01/2022 - 01/2006
14	Inflammation (Inflammations) 11/2022 - 08/2008
9	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2006
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2006
6	Arthritis (Polyarthritis) 12/2018 - 06/2002
5	Pain (Aches) 01/2022 - 04/2016
5	Myositis (Idiopathic Inflammatory Myopathies) 01/2020 - 12/2012
3	Lupus Nephritis 01/2016 - 01/2015
2	Hypersensitivity (Allergy) 01/2022 - 06/2005
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 11/2020
2	Nephritis 01/2021 - 02/2015
2	Arthralgia (Joint Pain) 04/2016 - 07/2013
2	Necrosis 10/2014 - 01/2006
2	Experimental Arthritis 07/2014 - 06/2002
1	Edema (Dropsy) 01/2022
1	Periodontitis 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Synovitis 01/2022
1	Spondylarthropathies 01/2022
1	Atherosclerosis 05/2021
1	Serum Sickness 01/2021
1	Human Influenza (Influenza) 01/2021
1	Antisynthetase syndrome 01/2020
1	Polymyositis 01/2019
1	Dermatomyositis (Dermatopolymyositis) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Fatigue 04/2017
1	Ankylosing Spondylitis 12/2016
1	Psoriatic Arthritis 12/2016
1	Myotoxicity 01/2016

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2008
21	AutoantibodiesIBA 01/2022 - 10/2012
19	AntibodiesIBA 01/2022 - 01/2007
15	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 01/2010
13	acetyl 4-aminosalicylic acidIBA 10/2020 - 01/2010
10	Peptides (Polypeptides)IBA 01/2022 - 12/2009
9	Immunoglobulin G (IgG)IBA 01/2022 - 01/2007
9	AntigensIBA 01/2022 - 08/2008
8	AutoantigensIBA 01/2020 - 08/2008
7	EpitopesIBA 01/2022 - 06/2002
7	CitrullineIBA 01/2022 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 12/2018 - 07/2013
6	Collagen Type II (Type II Collagen)IBA 01/2016 - 06/2002
4	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 12/2009
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017 - 06/2002
4	Phosphopyruvate Hydratase (Enolase)IBA 01/2017 - 08/2008
3	Monoclonal AntibodiesIBA 01/2022 - 01/2019
3	Rituximab (Mabthera)FDA Link 01/2022 - 01/2006
3	serum P-component (CIt)IBA 12/2021 - 01/2016
3	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 03/2013
3	ChemokinesIBA 02/2017 - 04/2016
3	HLA-DRB1*04:01 antigenIBA 01/2017 - 10/2011
3	Interleukin-17 (Interleukin 17)IBA 02/2015 - 01/2011
3	LigandsIBA 01/2015 - 01/2006
2	RNA (Ribonucleic Acid)IBA 11/2022 - 09/2016
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2011
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2021 - 11/2010
2	TenascinIBA 12/2021 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 04/2017
2	Rheumatoid FactorIBA 01/2021 - 01/2017
2	Immunoglobulin A (IgA)IBA 01/2021 - 07/2017
2	Interleukin-2 (IL2)IBA 01/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 12/2019 - 10/2014
2	Abatacept (Orencia)FDA Link 01/2019 - 08/2013
2	Fibrinogen (Factor I)FDA Link 12/2016 - 01/2010
2	B-Cell Activating FactorIBA 01/2015 - 10/2014
2	CytokinesIBA 10/2014 - 08/2011
1	Acid Sensing Ion ChannelsIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2022
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2022
1	Secretory Phospholipases A2IBA 01/2022
1	homocitrullineIBA 01/2022
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 01/2021
1	Extracellular Matrix ProteinsIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Myeloblastin (Proteinase 3)IBA 11/2020
1	CD40 Ligand (CD40L)IBA 01/2020
1	InterferonsIBA 01/2020
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2020
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2018
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 01/2018
1	Malondialdehyde (Propanedial)IBA 11/2017
1	Immunoglobulins (Immunoglobulin)IBA 08/2017
1	IgA receptor (protein B)IBA 07/2017
1	Fc Receptors (Fc Receptor)IBA 07/2017
1	Biological ProductsIBA 04/2017
1	Prostaglandins AIBA 04/2017
1	belimumabIBA 04/2017
1	Interleukin-8 (Interleukin 8)IBA 02/2017
1	DNA (Deoxyribonucleic Acid)IBA 09/2016
1	reparixinIBA 04/2016
1	PerforinIBA 01/2016
1	fluorexon (calcein)IBA 01/2016
1	Antiphospholipid AntibodiesIBA 01/2016

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2011
1	Retreatment 01/2021
1	Aftercare (After-Treatment) 02/2015